Tech Company Financing Transactions

Adnexus Therapeutics Funding Round

HBM Healthcare Investments, Atlas Venture and Flagship Pioneering joined a $15.5 million Series C funding round for Adnexus Therapeutics. The financing round was announced on 8/9/2007.

Transaction Overview

Company Name
Adnexus Therapeutics
Announced On
8/9/2007
Transaction Type
Venture Equity
Amount
$15,500,000
Round
Series C
Investors

HBM Healthcare Investments (Lead Investor) (Axel Bolte)

Atlas Venture (Jean-François Formela)

Flagship Pioneering (Patrick Gage)

Polaris Partners (Alan Crane)

Venrock (Anders Hove)

Proceeds Purpose
Adnexus Therapeutics intends to use the proceeds from the financing to, among other things, further fund clinical development activities of its product candidate, Angiocept (CT-322). In addition, Adnexus plans to continue to advance its pipeline of preclinical product candidates that span multiple disease areas.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
100 Beaver St.
Waltham, MA 02453
USA
Phone
(781) 891-3745
Website
www.adnexustx.com
Email Address
[email protected]
Overview
Adnexus is a private biotechnology company developing a breakthrough class of protein therapeutics known as AdNectins.
Profile
Adnexus Therapeutics LinkedIn Company Profile
Social Media
Adnexus Therapeutics Company Twitter Account
Company News
Adnexus Therapeutics News
Facebook
Adnexus Therapeutics on Facebook
YouTube
Adnexus Therapeutics on YouTube

Management Team

Title
Name
Email & Social
President
John Edwards
  John Edwards LinkedIn Profile  John Edwards Twitter Account  John Edwards News  John Edwards on Facebook
Vice President
Cliff Bechtold
  Cliff Bechtold LinkedIn Profile  Cliff Bechtold Twitter Account  Cliff Bechtold News  Cliff Bechtold on Facebook
Vice President
Ray Camphausen
  Ray Camphausen LinkedIn Profile  Ray Camphausen Twitter Account  Ray Camphausen News  Ray Camphausen on Facebook
Vice President
Sharon Cload
  Sharon Cload LinkedIn Profile  Sharon Cload Twitter Account  Sharon Cload News  Sharon Cload on Facebook
VP - Product Management
Kelledy Manson
  Kelledy Manson LinkedIn Profile  Kelledy Manson Twitter Account  Kelledy Manson News  Kelledy Manson on Facebook
VP - R & D
Eric Furfine
  Eric Furfine LinkedIn Profile  Eric Furfine Twitter Account  Eric Furfine News  Eric Furfine on Facebook

 

 

Browse more venture capital transactions:

Prev: 8/9/2007: Jacked venture capital transaction
Next: 8/9/2007: Xtera Communications venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to record every notable VC transaction. VC investment data records on this site come from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.